Trade Unlisted is not regulated by the Securities and Exchange Board of India (SEBI). Investments in unlisted securities involve significant risk, including the risk of complete loss of capital. The filing of a Draft Red Herring Prospectus (DRHP) does not guarantee that an Initial Public Offering (IPO) will occur. Unlisted securities are inherently illiquid, price discovery may be limited, and exit opportunities may not materialize.
Trade Unlisted provides news, insights, and general market information for informational and educational purposes only. The content should not be construed as financial, investment, legal, or tax advice. Trade Unlisted does not act as a broker, investment advisor, fiduciary, or intermediary, and does not endorse, recommend, solicit, or validate any investment opportunity. Users are solely responsible for conducting their own independent due diligence before making any financial or investment decisions.
All information is derived from publicly available sources and market observations. While reasonable care is taken in preparing content, Trade Unlisted makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of the information provided. Users should independently verify all information prior to relying on it.
Parag Parikh Flexi Cap Fund increased its stake in Coal India and seven other stocks while reducing holdings in three stocks in February
Parag Parikh Flexi Cap Fund increased its stake in Coal India and seven other stocks while reducing holdings in three stocks in February
Publish Date :
In February 2025, the Parag Parikh Flexi Cap Fund, managing assets totaling ₹88,004 crore, adjusted its investment portfolio by increasing stakes in eight companies and reducing holdings in three.
Increased Holdings:
Coal India: Added 33.01 lakh shares, raising total holdings to 14.26 crore shares.
Power Grid Corporation of India (PGCIL): Increased by 79.21 lakh shares.
Zydus Lifesciences: Gained an additional 26.20 lakh shares.
Other Increases: Enhanced positions in Dr. Reddy’s Laboratories, ITC, Cipla, Mahindra & Mahindra, and EID Parry India.
Reduced Holdings:
IPCA Laboratories: Decreased by 3.19 lakh shares.
Multi Commodity Exchange of India (MCX): Reduced by 84,417 shares.
ICRA: Lowered by 10,442 shares.
The fund did not introduce any new stocks or fully divest from existing ones during this period, reflecting its long-term investment approach focused on the individual merits of each stock.
As of February, the fund allocated 22.73% of its assets to cash, debt, and arbitrage positions, maintaining flexibility to capitalize on future investment opportunities.
Comments